🇺🇸 FDA
Patent

US 10864222

Beta-lactamase inhibitors, formulations, and uses thereof

granted A61KA61K31/407A61K31/665

Quick answer

US patent 10864222 (Beta-lactamase inhibitors, formulations, and uses thereof) held by The Regents of the University of California expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/407, A61K31/665, A61K31/675, A61K45/06